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HEALTH AND MEDICINE

Biomaterials with structural hierarchy and
controlled 3D nanotopography guide endogenous
bone regeneration
Shixuan Chen1, Hongjun Wang1, Valerio Luca Mainardi2,3, Giuseppe Talò4, Alec McCarthy1,
Johnson V. John1, Matthew J. Teusink5, Liu Hong6, Jingwei Xie1,7*
Biomaterials without exogenous cells or therapeutic agents often fail to achieve rapid endogenous bone regeneration with high quality. Here, we reported a class of three-dimensional (3D) nanofiber scaffolds with hierarchical
structure and controlled alignment for effective endogenous cranial bone regeneration. 3D scaffolds consisting
of radially aligned nanofibers guided and promoted the migration of bone marrow stem cells from the surrounding
region to the center in vitro. These scaffolds showed the highest new bone volume, surface coverage, and mineral
density among the tested groups in vivo. The regenerated bone exhibited a radially aligned fashion, closely recapitulating the scaffold’s architecture. The organic phase in regenerated bone showed an aligned, layered, and
densely packed structure, while the inorganic mineral phase showed a uniform distribution with smaller pore size
and an even distribution of stress upon the simulated compression. We expect that this study will inspire the design of next-generation biomaterials for effective endogenous bone regeneration with desired quality.
INTRODUCTION

Large calvarial bone defects often occur because of congenital
anomalies, trauma, stroke, aneurysms, and cancer (1, 2). Although
application of free vascularized bone grafts from distant sites may
represent the most reliable procedure, it is associated with issues
including the size and shape mismatch, bone resorption, and secondary morbidity (3). Regenerative medicine approaches involving
delivery of cells to defect sites have generated disappointing and inconsistent results (4). While recombinant human bone morphogenetic protein-2 (BMP-2) is currently approved for the bone repair
and regeneration, this therapeutic is associated with notable side
effects (e.g., ectopic bone formation and bone resorption) and high cost
(5, 6). Biomaterials including bioglass, titanium, poly(etheretherketone),
poly(methyl methacrylate), and hydroxyapatite have emerged for
cranioplasty (7). However, none of these conventional materials are
ideal likely due to their nonoptimal structures (e.g., small pore size,
low porosity, and lack of nanotopographical cues). In addition, most
cranioplasty materials are nonbiodegradable, resulting in restricted
growth and deformation of the skull in pediatric patients (8). Therefore, there is a great demand for development of inexpensive and
resorbable graft without incorporation of living cells and therapeutics,
eliminating the need for a second surgical site and substantial
drawbacks associated with the use of allografts, current cranioplasty
materials, and growth factors.
New biomaterials that can promote tissue repair and regeneration on their own without the need for cells or other therapeutics
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have emerged as a potentially powerful paradigm for regenerative
medicine (4). Topographical cues rendered by biomaterials have been
extensively investigated to guide cell response including adhesion,
spreading, alignment, migration, and gene expression (9, 10). In
particular, aligned topographical cues have been incorporated into
two-dimensional (2D) substrates created by electron beam lithography, colloidal lithography, photolithography, laser lithography, and
injection molding for in vitro regulation of cellular response (11–13).
Although these studies may provide useful information on the
design of biomaterials for regulating cell behavior, the 2D grooved/
patterned substrates are not physiologically relevant, lacking biomimetic property and capacity in forming aligned nanotopography
in 3D (14). Besides, the technical challenge still remains to incorporate 3D biomimicking, aligned nanotopographical cues into hierarchically structured biomaterials. To overcome these problems,
we reported a class of biomaterials made of polycaprolactone
(PCL) electrospun nanofibers with structural hierarchy and predesigned 3D aligned nanotopography and their evaluations in vitro
and in vivo in terms of cell response and bone regeneration efficacy.
We chose PCL as the raw material for nanofiber assemblies in that
it has been used in the U.S. Food and Drug Administration (FDA)–
approved implants and sutures (e.g., Osteoplug, Osteomesh, and
Monoderm) and is fully resorbable in 18 to 24 months (15, 16). The
gradual resorption profile makes it a predictable material for matching the natural stage of bone healing where cancellous bone tissues
completely form in about 6 months followed by remodeling phase
to cortical bones over 2 to 3 years (17). Similarly, we chose gelatin
for coating nanofiber assemblies as it has been used in FDA-approved
medical devices (e.g., Gelfoam) (18). We hypothesized that the 3D
scaffolds consisting of radially aligned nanofibers (RAS) and vertically aligned nanofibers (VAS) can guide and promote cell migration either from the surrounding to the center or from the bottom
to the top, resulting in rapid bone regeneration after implantation
to critical-sized calvarial bone defects in rats. Our approach
shows great promise for the development of next generation of
cell- and therapeutic agent–free biomaterials for effective endogenous
bone repair.
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RESULTS

Fabrication and characterization of RAS and VAS
RAS and VAS were fabricated by transformation of 2D electrospun
nanofiber membranes through the solids of revolution-inspired
gas-foaming expansion following our established protocols (19, 20).
Briefly, we cut the 2D mat consisting of uniaxially aligned nanofibers into a rectangular shape in liquid nitrogen. Then, we fixed one
side of the rectangular mat by thermal treatment. When the fixed
side was perpendicular to the direction of nanofiber alignment, we
would obtain a cylindrical RAS after expansion. In contrast, when
the fixed side was parallel to the direction of nanofiber alignment,
we would obtain a cylindrical VAS after expansion. A scanning
electron microscopy (SEM) image shows the top view of the RAS,
displaying radially distributed channels formed by expanded, layered membranes consisting of aligned nanofibers along the radius
direction, while the side view shows a porous structure (Fig. 1A).
The inset images indicate the fiber alignment in the radial direction
(Fig. 1A). In contrast, SEM images of the top view of the VAS reveal
a highly porous structure formed by crimped, layered membranes
consisting of aligned fibers along the axial direction, while the side
view showing a channel structure (Fig. 1B). The inset images indicate the fiber alignment in the axial direction (Fig. 1B). The porosity
and pore size of RAS and VAS can be tailorable by controlling the
thickness of PCL nanofiber mat before expansion (fig. S1, A and B).
The porosities of the RAS that were fabricated by expanding 0.5-,
1-, and 1.5-mm-thick PCL nanofiber mats were (80.81 ± 8.16%),

(70.90 ± 5.6%), (49.80 ± 6.72%), respectively (fig. S1, C and D). The
corresponding average pore sizes were (884.42 ± 439.92 m),
(283.12 ± 138.64 m), and (106.86 ± 60.51 m) accordingly. The
porosities of the VAS that were fabricated by expanding 0.75-, 1-,
and 1.5-mm-thick PCL nanofiber mats were (76.52 ± 4.93%),
(68.60 ± 6.11%), (64.01 ± 5.27%), respectively. The average pore sizes
were (1024.68 ± 357.01 m), (417.39 ± 153.39 m), and
(246.84 ± 119.08 m) accordingly.
It is observed that the pore size of the RAS and VAS gradually
increased from the center to the edge. To quantify the pore size distribution in the RAS and VAS, four regions were defined from the
center to the edge (Fig. 1, C and D). The average pore sizes in the
regions 1 to 4 of the RAS were (57.45 ± 30.43 m), (177.31 ± 36.96 m),
(331.21 ± 64.47 m), and (494.33 ± 66.26 m) (Fig. 1E). In comparison, the average pore sizes in the regions of 1 to 4 of the VAS were
(129.09 ± 22.55 m), (268.79 ± 53.50 m), (503.43 ± 77.15 m), and
(872.06 ± 110.66 m) (Fig. 1F). In addition, the channel lengths
within the RAS and VAS were also quantified. The channel lengths
in the RAS were mainly in the range of 2 to 2.5 mm, and the channels with a length over 2 mm accounted for 56.25% (Fig. 1, G and H).
The channel lengths of the VAS were mainly in the range of 0.8 to
1 mm, and all the channels had a length over 0.6 mm (Fig. 1, I and J).
For comparison, collagen sponges were examined by SEM, exhibiting a uniform porous structure in all dimensions and the average
pore size was (143.42 ± 55.21 m) (fig. S2). The mechanical properties of RAS and VAS in different directions were examined under

Fig. 1. Characterizations of RAS and VAS. (A and B) SEM images of the top view and side view of RAS and VAS. Insets: Highly magnified SEM images of (A) and (B) indicated the fiber alignment in RAS and VAS. (C and D) Schematic illustrating the four regions of RAS and VAS from the center to edge. (E and F) The corresponding average
pore size of each region in RAS and VAS. (G and H) Schematic illustrating the channels along the radial direction of RAS and their corresponding length distribution. (I and
J) Schematic illustrating the channels along the longitudinal direction of VAS and their corresponding length distribution. **P < 0.01.
Chen et al., Sci. Adv. 2021; 7 : eabg3089
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70% of compressive strain (fig. S3). The resultant compressive
stresses of VAS in the side and frontal directions were similar (fig.
S3). The compressive stress of RAS was much higher in the frontal
direction than in the side direction when compressive strain was
70% (fig. S3).
RAS and VAS guide bone marrow stem cell migration
and promote bone regeneration related gene expression
In the RAS, the open pores toward the surrounding healthy bone
could guide and promote cell infiltration from the surrounding healthy
bone to the defect site, while in the VAS, the open pores toward
periosteum and dura could guide and promote cell infiltration from
periosteum and dura to the defect site. Thus, we established two
different in vitro migration models to examine the efficacy of RAS
and VAS in guiding and promoting cell migration (fig. S4) (20). Bone
marrow stem cells (BMSCs) were chosen for this study as they are
the major and important cell source for bone regeneration (21).
In the first model, the marginal BMSC migration was observed from
the bottom to the top through RAS during 6 days of culturing, while
the significant BMSC migration was detected from the bottom to the
top through VAS (Fig. 2A). In particular, some BMSCs migrated
to the top of VAS after 4 and 6 days of incubation (Fig. 2, A and B).
In the second model, the sparsely distributed BMSCs were observed
after 4 days of incubation, and more and more cells were detected
after 8 and 12 days throughout the whole RAS, while BMSCs were
mainly located at the edge of VAS during the incubating period
(Fig. 2C and fig. S5). The migrated BMSCs covered the half surface
of the RAS after 12 days of infiltration (Fig. 2D). The potential
mechanism discovers that the BMSCs prefer to migrate from the
bottom to the top within the VAS (Fig. 2, E and F) and from the
edge to the center within the RAS (Fig. 2, G and H), which is mainly
caused by the guiding role of aligned nanofibers on cell migration.
To investigate the expression of growth factors, extracellular
matrix (ECM), proliferation, and apoptosis-related genes of BMSCs
cultured on the RAS, we performed the heatmap analysis on the
expression of BMP-2, basic fibroblast growth factor (bFGF), vascular
endothelial growth factor (VEGF), platelet derived growth factor-BB
(PDGF-BB), insulin-like growth factor 1 (IGF-1), transforming growth
factor–1 (TGF-1), collagen 1, CXCR4, cyclin D1, CDK1, caspase-3,
and BCL-2 genes of BMSCs on the RAS after culture for 5 and 9 days
(Fig. 2I). The relative expression of BMP-2, bFGF, PDGF-BB, TGF-1,
type 1 collagen, CXCR4, and cyclin D1 of the BMSCs cultured on
RAS was significantly increased compared to the BMSCs cultured
in the petri dish after 5 days of incubation (Fig. 2J). After incubation for
9 days, the relative expression of BMP-2, bFGF, VEGF, PDGF-BB,
IGF-1, TGF-1, type 1 collagen, and cyclin D1 of the BMSCs cultured
on RAS was significantly higher than those of the BMSCs cultured
in petri dish (Fig. 2K). In addition, we also performed the heatmap
analysis of BMSCs cultured on the VAS (fig. S6). By comparison, the
VEGF relative expression of BMSCs was higher on the VAS than on
the RAS. In addition, the cyclin D1 relative expression of BMSCs
was lower on the VAS than on the RAS. The rest of tested markers
for BMSCs showed similar expression levels on the VAS and RAS.
RAS and VAS accelerate cranial bone regeneration
To test the bone regeneration efficacy of RAS and VAS, we implanted
these scaffolds into the critical-sized (8 mm in diameter) calvarial
bone defects in rats (Fig. 3A) (22–24). The schematic diagrams
indicate the open pores on the side of the RAS facing the bone marrow
Chen et al., Sci. Adv. 2021; 7 : eabg3089
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(Fig. 3B), and the open pores on the bottom and top of the VAS
facing periosteum and dura matter after implantation, respectively
(Fig. 3C). The schematic and surgical photographs reveal the treatment groups including control, RAS, VAS, and collagen sponges
(fig. S7). After 4 and 8 weeks of implantation, the isolated tissues
from bone defects and surrounding areas were imaged by micro–
computed tomography (micro-CT). It is evident that more new bones
were formed in both RAS and VAS groups compared to the control
and collagen groups, particularly after 4 weeks of implantation
(Fig. 3, D and E, and fig. S5). On the basis of the quantification from
micro-CT images (25), the regenerated bone volume, surface coverage, and bone mineral density in the RAS group were markedly
higher than those in the control, VAS, and collagen sponge groups
(Fig. 3, F to H). The newly formed bone in the RAS and VAS groups
showed a radially aligned structure and a honeycomb structure at
both weeks 4 and 8, closely recapitulating the architectures of RAS
and VAS (Fig. 3, D and E, and movies S1 and S2). In addition, the
surface of the regenerated bone in the control and collagen sponge
groups was smoother and flatter than the RAS and VAS groups
(Fig. 3, D and E, and movies S3 and S4).
We further performed the trichrome staining of the isolated tissues from the defect sites and the surround areas. It is found that the
defect sites in the control group were mainly filled with fibrotic tissues after 4 and 8 weeks of surgery (Fig. 3I and fig. S8). Only a small
amount of new bone was formed at the edges of the defects (Fig. 3I
and fig. S8). Similarly, the bone defects were mostly composed of
fibrotic tissues after treatment of collagen sponges for 4 weeks (fig.
S8). Although some newly formed bone tissues were detected in the
collagen sponge group after 8 weeks of implantation, there was still
a residual bone defect that did not completely close (Fig. 3I). In contrast,
a large amount of newly formed bone was observed throughout the
whole defect area in the RAS and VAS groups at as early as week 4,
which were in line with the micro-CT results (Fig. 3, D and I). After
8 weeks of implantation, more regenerated bone tissues were seen
over the entire defect regions in the RAS group that almost closed
the defects (Fig. 3I). In both RAS and VAS groups, although no visible PCL nanofibers were seen within the newly formed bone tissues
after 8 weeks, PCL nanofibers were not fully degraded because of
their slow degradation rate. We speculate that the PCL nanofibers
could be embedded within the newly formed bone tissues and integrate well with new tissues because of the high porosity and nanofibrous morphology of assemblies.
The second harmonic generation microscopy (SHGM) was used
to characterize the organization of collagen fibers in the organic phase
of the regenerated bone matrix after 8 weeks of operation (26, 27).
The SHGM images and the corresponding distributions of collagen
fiber orientation were shown in Fig. 3J. It is observed that the orientation of collagen fibers in the organic phase of newly formed bone
matrix was along the direction of nanofiber alignment in the RAS
and VAS groups (Fig. 3J). On the contrary, collagen fibers were randomly
distributed in the organic phase of newly formed bone matrix in the
control and collagen sponge groups (Fig. 3J). The alignment score
of collagen fibers of the RAS and VAS group was higher than the
control and collagen groups (Fig. 3K). We also performed the type
2 collagen immunohistochemical staining (fig. S9). No visible type
2 collagen–positive areas were detected in the control and collagen
groups because there was no significant new bone formation in
these groups after 4 weeks of surgery (fig. S9A). The RAS and VAS
groups had a significantly higher expression of type 2 collagen than
3 of 14
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Fig. 2. 3D Nanotopographical cues promote the migration and bone regeneration–related gene expression of BMSCs. (A) Fluorescent images show the migration
of BMSCs from the bottom to the top of RAS and VAS. (B) Quantification of the migrated distance of BMSCs from the bottom to the top of RAS and VAS. (C) Fluorescent
images show the distribution of migrated BMSCs from the surrounding area to the center of the RAS and VAS. (D) The surface coverage of BMSCs migrated to RAS and
VAS. (E and F) Schematic illustrating the possible migration route of BMSCs from the bottom to the top of RAS and VAS. (G and H) Schematic illustrating the possible
migration route of BMSCs from the surrounding area to the center of RAS and VAS. (I) The heatmap shows the relative expression of BMP-2, bFGF, VEGF, PDGF-BB, insulin-
like growth factor 1 (IGF-1), transforming growth factor–1 (TGF-1), Collagen 1, CXCR4, Cyclin D1, CDK1, Caspase-3, and BCL-2 of BMSCs cultured in RAS for 5 and 9 days.
Blue color indicates down-regulation, and red color indicates up-regulation. (J and K) The relative expression of BMP-2, bFGF, VEGF, PDGF-BB, IGF-1, TGF-1, Collagen 1,
CXCR4, Cyclin D1, CDK1, Caspase-3, and BCL-2 of BMSCs cultured in RAS for 5 and 9 days. **P < 0.01.

the control and collagen sponge groups at week 4 (fig. S9B). At week 8,
RAS, VAS, and collagen sponge groups showed higher expression
of type 2 collagen than the control group (fig. S9B). In addition, we
did not find significant difference in the type 2 collagen expression
among the RAS, VAS, and collagen sponge groups after 8 weeks of
surgery (fig. S9B).
Chen et al., Sci. Adv. 2021; 7 : eabg3089
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RAS and VAS guide the bone matrix formation
The bone ECM matrix consists of an organic phase (~30 to 40%)
and an inorganic mineral phase (~60 to 70%) (28, 29). To further
understand the guidance of RAS and VAS, the decalcified, newly
formed bone tissues (the organic phase of the regenerated bone matrix)
was examined by SEM. It is confirmed that the top (close to periosteum)
4 of 14
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Fig. 3. RAS and VAS guides cranial bone regeneration. (A to C) Schematic illustrating the implantation of RAS and VAS to critical-sized cranial bone defects in rats and
cross views of the interfaces between RAS, VAS, and surrounding tissues after implantation. (D and E) Micro-CT images of the control, RAS, VAS, and collagen sponge
groups after 4 and 8 weeks of operation. (F to H) The regenerated bone volume (%), surface coverage (%), and bone mineral density (%) of the control, RAS, VAS, and
collagen sponge groups after 4 and 8 weeks of operation. The bone volume and mineral density of the harvested cranial bone (8 mm in diameter) at the same surgical
site from a 4-month-old rat are 32.18 mm3 and 0.157 g/cm3, respectively. The bone volume and mineral density of the harvested cranial bone (8 mm in diameter) at the
same surgical site from a 5-month-old rat are 33.97 mm3 and 0.171 g/cm3, respectively. (I) The trichrome staining of isolated tissues from the control, RAS, VAS, and
collagen sponge groups after 4 and 8 weeks of operation. Green dot lines indicate the edge of defects. S, scaffold; NB, new bone. (J) second harmonic generation microscopy
(SHGM) images of collagen fibers in the organic phase of the regenerated bone and the corresponding distributions of orientations of collagen fibers after 8 weeks of
operation. (K) The alignment score of the collagen fibers in the control, RAS, VAS, and collagen sponge groups after 8 weeks of operation. *P < 0.05, **P < 0.01. Control,
no scaffold treatment.
Chen et al., Sci. Adv. 2021; 7 : eabg3089
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and bottom (close to dura matter) parts of the native cranial bone
are the compact bone exhibiting a layered, aligned structure. The
middle part is the spongy bone exhibiting a random or partially
aligned structure (Fig. 4A). Fibrotic tissues consisting of random
fibers were mainly found in the defect sites in the control group at
both weeks 4 and 8 (Fig. 4B). The organic phase of newly formed
bone matrix at the edge of the defects showed a porous structure
(fig. S10A). In contrast, the organic phase of the regenerated bone
matrix showed a densely aligned structure after implantation of
RAS for 4 and 8 weeks akin to that of the compact bone matrix
(Fig. 4, A, B, and D). Differently, other than the fibrotic tissues (fig.
S10B), the organic phase of the newly formed bone matrix showed

an unordered, porous structure at the defect site after treatment of
VAS for 4 weeks. The organic phase in the regenerated bone matrix may
help illustrate how the new bone was formed within the VAS. The
new bone could form underneath the VAS first due to BMSCs and
bone progenitor cells migrated from the surrounding bone marrow
and dura, and then the new bone could continuously grow from the
bottom to the top of the VAS due to the migration of BMSCs or
bone progenitor cells along the fiber alignment direction (fig. S10C).
Most of the newly formed organic phase of the regenerated bone
matrix within the VAS seemed immature after 4 weeks of implant
ation. A more mature organic phase in the regenerated bone matrix
was noticed after implantation of VAS for 8 weeks (Fig. 4, B and E).

Fig. 4. RAS and VAS guide the formation of organic phase in regenerated cranial bone matrix. (A) SEM images show the organic phase of native cranial bone matrix
after decalcification. The top and bottom parts are the compact bone with densely aligned structure. The middle part is the spongy bone with less dense and less ordered
structure. (B) SEM images show the morphologies of the decalcified, regenerated bone tissues in the defect areas in the control, RAS, VAS, and collagen sponge groups
after 4 and 8 weeks of operation. The red double arrows indicate the direction of nanofiber alignment. (C) Quantification of the thicknesses of regenerated bone matrix
with densely aligned structure in the control, RAS, VAS, and collagen sponge groups after 4 and 8 weeks of operation. (D and E) The specified decalcified bone matrix of
the RAS and VAS groups after 4 and 8 weeks of operation. The red double arrows indicate the direction of nanofibers. **P < 0.01 Control, no scaffold treatment.
Chen et al., Sci. Adv. 2021; 7 : eabg3089
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In addition, the bone defects showed a porous structure filling with
a number of round shaped cells after implantation of collagen
sponges for 4 weeks (Fig. 4B). The organic phase in the regenerated
bone matrixes showed both the dense (bottom) and porous (top)
regions after implantation of VAS for 8 weeks (Fig. 4B). The thickness of the organic phase in the regenerated bone matrix in the RAS
group was significantly higher than the control, VAS, and collagen
groups (Fig. 4C).
Besides the organic phase, we also analyzed the inorganic phase
in the regenerated bone matrix based on micro-CT images. As shown
in Fig. 5A, the inorganic phase of regenerated cranial bone was not
very homogeneous. This could be due to the insufficient time of
remodeling of regenerated bone as the duration for bone regeneration was only 8 weeks. The regenerated bone would undergo further
remodeling, and the thickness of regenerated bone would eventually
become similar to native bone after remodeling. In the microstructure,
the mineral phase in native cranial bone showed a bridge structure
containing some large pores. Large pores were also found in the
newly formed minerals in the control and collagen sponge groups.
In the contrast, smaller pores were observed in the newly created
minerals in the RAS and VAS groups (Fig. 5, A and B). To further
understand the mechanical function of regenerated bone, we evaluated the distribution of stress on the newly formed mineral phase
after implantation for 8 weeks based on computational simulations
using COMSOL Multiphysics. The colored whole image and three
parallel section planes of the newly formed minerals in the control,
VAS, and collagen sponge groups showed an uneven Mises stress
distribution (Fig. 5C). In particular, in the VAS and collagen sponge
groups, the high Mises stress existed around the large pore. An even
Mises stress distribution was seen in the healthy cranial bone minerals
and the newly formed mineral phase in the RAS group. In the present
study, the stress distribution simulation based on the micro-CT
data demonstrated that the internal structure of newly formed cranial bone was relatively uniform after implantation of RAS scaffolds,
which is close to the normal cranial bone. The quantification of
average Mises stress in the control, RAS, and VAS was higher than
that in the healthy bone and RAS group. The mineral phase in the
healthy cranial bone had a similar average Mises stress as the RAS
group (Fig. 5D).
Biomaterials reveal the role of endogenous cells on cranial
bone regeneration
To explore the contribution of endogenous cells to the cranial bone
regeneration, we designed and tested three different configurations
of biomaterials [RAS + nanofiber membranes for blocking cell penetration from the side and the bottom direction (SB), RAS + nanofiber
membranes for blocking cell penetration from the side and the top
direction (ST), and RAS + nanofiber membranes for blocking cell
penetration from the top and the bottom direction (TB)] in the same
critical-sized rat calvarial bone defect model (Fig. 6A). The nanofiber membranes for blocking cell penetration were made of pure
PCL. The distributions of regenerated bone differed from one another
among the SB, ST, and TB groups (Fig. 6, B to D, and fig. S11). Specifically, in the SB group, a large area of newly formed bone with
limited thickness was detected underneath the nanofiber membrane
placed on the bottom of RAS (Fig. 6, B to D, and movie S5). No evident
new bone formation was seen within RAS (Fig. 6B). In the ST group,
significant amount of new bone with a radially aligned structure
was detected within RAS (Fig. 6, B to D). Meanwhile, a thin layer of
Chen et al., Sci. Adv. 2021; 7 : eabg3089

28 July 2021

bone was formed on the surface of the nanofiber membrane close to
periosteum (Fig. 6B and movie S6). In the TB group, the regenerated
bone tissues were distributed in three different regions including a
thin layer of bone on the surface of nanofiber membrane adjacent to
periosteum, a relative thick layer of bone underneath the nanofiber membrane facing dura matter, and a small amount of bone
within RAS (Fig. 6B and movie S7). On the basis of the quantified
micro-CT results, no significant difference in the regenerated bone
volume was detected among the ST, SB, and TB groups after 4 and
8 weeks of operation (Fig. 6E). However, the surface coverage of the
TB group was significantly higher than the ST and SB groups after
8 weeks of treatment (Fig. 6F). Besides, the mineral density of regenerated bone in the ST and TB groups were higher than the SB group
(Fig. 6G). To confirm the micro-CT results, we further performed
the trichrome staining of isolated tissues from bone defects and surrounding areas (Fig. 6H). It is verified that the newly formed bone
was located underneath the nanofiber membrane in the SB group.
There were two regions of new bone in the ST group. One was
located on the surface of nanofiber membrane facing periosteum,
and the other was inside RAS. Three distinct regions of new bone
including the nanofiber membrane surface facing periosteum,
within RAS, and the nanofiber membrane surface facing dura matter were observed in the TB group similar to the micro-CT results
(Fig. 6, D and H).
DISCUSSION

Aligned nanotopographical cues have been widely demonstrated for
positive regulation of cellular responses such as guiding and promoting cell migration and cell differentiation, holding great promise
for tissue regeneration (30–34). However, current technologies are
mainly limited to generation of the patterned grooves or aligned
nanofiber membranes in a 2D form, which may not be able to match
the geometric shape of tissue defects. To this end, we developed a
solid of revolution inspired gas-foaming technique to convert traditional electrospun nanofiber mats into 3D objects with hierarchy
structure and controlled alignment (e.g., RAS and VAS) (19, 20).
The RAS and VAS can promote not only BMSC migration along the
direction of fiber alignment from the surrounding to the center and
from the bottom to the top but also the expression of bone regeneration related genes in vitro. In vivo studies demonstrated RAS and
VAS can guide endogenous bone regeneration rapidly as the regenerated bone within RAS and VAS showed a radially aligned pattern
and a honeycomb pattern, closely recapitulating the architectures of
RAS and VAS.
The cranial bone regeneration efficacy of RAS and VAS was
much higher than the control and collagen sponge groups after
4 weeks of implantation, which was also far superior to the ones of
reported biomaterials tested in the same animal model including the
nanofiber aerogels, 3D-printed scaffolds, injectable thermo hydrogel, hybrid hydrogels, macroporous calcium phosphate, nano-
hydroxyapatite bone substitute, and deproteinized bovine bone
(23, 24, 35–40). Furthermore, these biomaterials even incorporated
with stem cells and therapeutic agents still had inferior perform
ance relative to RAS and VAS (36, 38, 40). We speculate that the
hierarchical structure and 3D aligned nanotopography in RAS and
VAS could be critical for effective guidance of endogenous bone
regeneration. We believe that the guidance and promotion of cell
infiltration from specific directions are the keys for cranial bone
7 of 14
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Fig. 5. RAS and VAS influence the configurations of the inorganic phase in regenerated cranial bone matrix. (A) Macrostructures of minerals within the native
cranial bone and the regenerated bone tissues of the control, RAS, VAS, and collagen sponge groups. (B) High magnifications of (A). (C) Computational simulations of Von
Mises stress distributions of control (ii), RAS (iii), VAS (iv), and collagen sponge (v) groups after 8 weeks of treatment. (D) Quantification of the average Von Mises stress in
the native cranial bone, control, RAS, VAS, and collagen sponge groups after 8 weeks of treatment. **P < 0.01. Healthy group is the cranial bone with the same age and
without any surgery, which was used for comparison as a positive control. Control, no scaffold treatment.

regeneration. This is partially supported by the in vitro BMSC migration and heatmap analysis results. The directed and accelerated
BMSC migration and enhanced expression of bone regeneration
related genes in BMSCs may play important roles for repairing
Chen et al., Sci. Adv. 2021; 7 : eabg3089
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critical-sized cranial bone defects as the cranial vault bones are
mainly formed by intramembranous ossification. The underlying molecular mechanism on the BMSC response regulated by
2D patterned surfaces was investigated previously, which could be
8 of 14
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Fig. 6. Combining 2D nanofiber membranes with RAS reveals the roles of tissue sources on cranial bone regeneration. (A) Schematic illustrating the experimental
designs including SB (RAS was attached by 2D nanofiber membranes on the lateral and bottom surfaces), ST (RAS was attached by 2D nanofiber membranes on the lateral and top surfaces), and TB (RAS was attached by 2D nanofiber membranes on the top and the bottom surfaces). (B) Micro-CT images show the cross sections of regenerated bone in the SB, ST, and TB groups after 4 and 8 weeks of operation. (C and D) Micro-CT images of the front and back views of regenerated bone in the SB, ST, and
TB groups after 4 and 8 weeks of operation. (E to G) The regenerated bone volume (%), surface coverage (%), and mineral density (%) of the SB, ST, and TB groups after
4 and 8 weeks of operation. (H) Trichrome staining of regenerated bone tissues in SB, ST, and TB groups after 4 and 8 weeks of operation, indicating the distinct regions
of newly formed bone in the SB, ST, and TB groups. Green dot lines indicate the edge of bone defects. *P < 0.05, **P < 0.01.

associated with the down-regulation of Zyxin protein expression in
BMSCs (41). The decreased Zyxin expression may lead to smaller
and more dynamic focal adhesion and reduced traction forces,
resulting in faster and more directional migration of BMSCs. Such
a mechanism could be used to explain the guidance and promotion of BMSCs cultured on RAS and VAS as well. In addition, the
regenerated bone showed a radially aligned arrangement and a
honeycomb pattern in RAS and VAS, closely mimicking the architectures of RAS and VAS, which could further confirm their guidance on endogenous bone regeneration. In addition, the positive
Chen et al., Sci. Adv. 2021; 7 : eabg3089
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immunohistochemical staining of type 2 collagen suggests that
endochondral bone formation could play certain role in the new
bone formation as well.
The regenerated ECM could provide indications of quality of
newly formed bone tissues. The organic phase of the regenerated
bone after demineralization showed a compact layered structure
with certain alignment in the RAS group after 8 weeks of treatment,
which seems similar to the structure of compact bone. This could be
important as compact bone plays a dominant role in maintaining
the mechanical property of the entire skull (42). The RAS group also
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had much thicker densely packed organic matrix than other groups.
In addition, on the basis of the SHG imaging results, the alignment
score of collagen fibers in the RAS and VAS groups was higher than
the control and collagen groups. However, the aligned collagen fibers only served as a temporary matrix that would be remodeled to
native structure. The process of bone remodeling takes about 2 to
3 years. Furthermore, the inorganic phase of the regenerated ECM
in the RAS group showed a uniform distribution of minerals with
smaller pore size and lower Von Mises stress distribution when
compared with other groups. On the basis of the structure of ECM
and Von Mises stress simulation, regenerated bone in the RAS
group may be able to endure higher mechanical stress, which could
rapidly establish protection of the underlying brain. This type of
biomaterials could also be useful for repairing bone defects of
patients with osteoporosis as their bones are highly porous with low
load bearing.
In addition, to reveal the contribution of different tissue sources
to cranial bone regeneration in the RAS group, 2D nanofiber membranes served as a physical barrier were used to selectively inhibit
cellular infiltration from different tissue sources due to their small
pore size (43–45). Because of the high porosity, the membranes
should have marginal influence on the diffusion of paracrine factors
secreted by various tissue sources, nutrients, and wastes to the defect site (45). When the side and bottom of RAS were blocked by
nanofiber membranes, although the top area of RAS was open for
cell infiltration, new bone tissues preferred to form underneath the
nanofiber membrane facing dura matter, resulting in a thin layer of
regenerated bone. This result indicates the regenerated bone was likely
attributed to the migration and differentiation of bone progenitor
cells from surrounding bone marrow or dura matter. On the basis
of the trichrome staining results, the nanofiber membranes effectively blocked cell infiltration into RAS from the side and bottom,
and it seems that the regenerated bone was mainly contributed by
the bone progenitor cells migrated from surrounding bone tissues
to the sites below the nanofiber membrane facing dura matter.
When the side and top of RAS were blocked by nanofiber membranes, the bottom of RAS was open for cell penetration. Unexpectedly, there were two regions of newly formed bone. The
regenerated bone on the surface of nanofiber membrane facing
periosteum could be due to the migration and differentiation of
bone progenitor cells from surrounding bone tissues, while the
newly formed bone within RAS may be attributed to the migration
and differentiation of bone progenitor cells from dura matter or
surrounding bone tissues. When the top and bottom of RAS were
blocked by nanofiber membranes, the side of RAS was open for tissue ingrowth. The bone progenitor cells not only migrated along
the top and bottom surface of the nanofiber membranes but also
infiltrated into RAS through the side pores, resulting in formation
of three regions of regenerated bone. These results suggest that the
surrounding bone and dura matter play important roles in cranial
bone regeneration, and the contribution of periosteum is marginal,
which partially agrees with previous studies (46, 47). In addition,
the strategy presented in this study could inspire the design of
next-generation biomaterials for effective guidance of endogenous
tissue regeneration at a fast pace. Furthermore, our recent studies
have examined the scale-up production of nanofiber assemblies,
and the scaffolds with clinically relevant dimensions can be readily
fabricated using a large electrospinning setup and a similar expansion procedure (48, 49).
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MATERIALS AND METHODS

Materials
Study design
This research is dedicated to the development of cell- and therapeutic
agent–free biomaterials for effective repairing large calvarial bone defects that may be readily translated into clinical applications. 3D PCL
nanofiber scaffolds coated with 0.5% gelatin were prepared reproducibly as bone grafts to guide the regeneration of 8-mm rat calvarial
bone defects. These scaffolds were thoroughly characterized in terms of
their morphology, structure, fiber alignment, porosity, and pore size.
The in vitro migration and differentiation of BMSCs were further
performed to illustrate the importance of aligned nanotopography rendered by 3D nanofiber scaffolds. The scaffolds were then implanted into 8-mm bone defects surgically created in rat skulls. The
8-mm rat cranial bone defect is a critical-sized defect that cannot heal
on its own (18). This defect model was chosen to rigorously examine
the in vivo efficacy of 3D nanofiber scaffolds with hierarchical structure
and controlled alignment. All the rats were randomly assigned, and
12 rats were assigned to each group. The animal study was approved by
Institutional Animal Care and Use Committee (IACUC) at the University of Nebraska Medical Center (UNMC). Bone regeneration was
characterized by micro-CT after 4 and 8 weeks and histology. The collagen organization in the regenerated tissues after demineralization
was characterized by SHGM. The distribution of stress on the regenerated mineral phase after 8 weeks was evaluated on the basis of the
micro-CT images and computational simulations. The data obtained
from all the rats were taken into consideration. In the presented figures,
we used scatterplots to indicate the data obtained from the animal study.
Materials
PCL (molecular weight = 80 kDa), pluronic-F-127, gelatin, sodium
borohydride, and Triton X-100 were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Dichloromethane (DCM) and N,N′-
dimethylformamide (DMF) were purchased from BDH Chemicals
(Dawsonville, GA, USA). Dulbecco’s modified Eagle’s medium, fetal
bovine serum, and penicillin-streptomycin were obtained from
Invitrogen (Carlsbad, CA, USA). Alexa Fluor 546 phalloidin was purchased from Abcam (Cambridge, MA, USA). Collagen bovine plugs
were obtained from Integra LifeSciences Corporation (Plainsboro,
NJ, USA). The RNeasy Mini Kit was ordered from QIAGEN (Hilden,
Germany). All primers used for reverse transcription polymerase
chain reaction (RT-PCR) test were purchased from Eurofins (Bothell,
WA, USA). cDNA reverse transcription reagent kits were ordered
from Quantabio (Beverly, MA, USA). SYBR Green detecting system
was purchased from Bio-Rad (Hercules, CA, USA).
Fabrication of RAS, VAS, and collagen sponges
The RAS and VAS were prepared using a modified method from
our previous studies (15, 16). PCL/0.5% F127 nanofiber mats with a
thickness of 1 mm were first produced by traditional electrospinning
with a rotating mandrel as a collector. Two grams of PCL beads and
0.1 g of F127 were dissolved in 20 ml of DCM and DMF mixed solvent at a ratio of 4:1 (v/v), the final concentration of PCL is 10% and
the final concentration of F127 is 0.5%. After PCL/F127 solution
was completely dissolved, 50 ml of PCL/F127 solution was pumped
at a flow rate of 0.7 ml/hour using a syringe pump while a potential
of 18 kV was applied between the spinneret (22-gauge needle) and a
grounded collector. Around 1-mm-thick uniaxially aligned PCL/
F127 nanofiber mat was collected by a high-speed rotating drum.
Subsequently, the mats were cut into rectangle shape in liquid nitrogen along the direction of nanofiber alignment or perpendicular
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to the long axis of nanofibers [5 mm (width) × 15 mm (length)].
Then, the long side of these PCL/F-127 nanofiber mats was fixed by
thermal treatment (85°C for 1 s). Subsequently, these mats were
transferred into 1 M NaBH4 solution and expanded for 30 min to
form RAS and VAS. After expansion, the RAS and VAS were washed
with distilled water under a vacuum (∼200 Pa) for 10 s. This washing process was repeated three times. The distilled water was then
removed, and the RAS and VAS were exposed to a vacuum until it
froze and then freeze-dried. The RAS and VAS were further coated
with a 0.5% gelatin solution for 10 min to enhance their mechanical
property. These 3D scaffolds were exposed to a vacuum until they
froze and then freeze-dried after the residual gelatin solution was
removed. Last, the gelatin-coated RAS and VAS with a height of
15 mm were cut into RAS and VAS with a height of 1 mm. The RAS
and VAS with a thickness of 1 mm were further punched by an
8-mm punch. Similarly, the collagen sponges were made by cutting
and punching the commercial absorbable collagen bovine plugs into
disks (diameter: 8 mm; thickness: 1 mm).
Fabrication of RAS and VAS with different porosities
and pore sizes
Briefly, the 0.5-, 1-, and 1.5-mm-thick PCL/0.5% F-127 nanofiber
mats were cut into pieces [5 mm (width) × 15 mm (length)] with
rectangle shape along the direction perpendicular to the long axis of
nanofibers. These mats were also cut into pieces [5 mm (width) ×
15 mm (length)] with rectangle shape along the direction of long
axis of nanofibers. Then, the expansion, gelatin coating, and punching processes were performed as abovementioned. Last, the RAS
and VAS with different porosities and pore sizes were obtained.
Fabrication of ST, SB, and TB
The RAS with 1 mm in thickness and 8 mm in diameter were prepared as described above. PCL nanofiber mats with 200 m thick
were prepared following our previous studies. ST was fabricated by
covering the side and top surface of RAS with nanofiber mats. SB
was fabricated by covering the side and bottom surface of RAS with
nanofiber mats. TB was fabricated by covering the top and bottom
surfaces of RAS with nanofiber mats. All the covered nanofiber
mats were fixed to RAS with DCM solvent. Last, ST, SB, and TB
were placed in the fume hood for 3 days to remove the residual
DCM solvent.
Characterization of biomaterials
The RAS, VAS, collagen sponges, and tissue samples isolated from
the control, RAS, VAS, and collagen sponge groups and sectioned
by cryo-cutting were coated with Pt for 5 min using a Pt sputter
coater and imaged by a SEM under 25 kV (FEI, Quanta 200, Billerica,
MA, USA). The porosities and pore sizes of RAS and VAS expanded
from 0.5-, 1-, and 1.5-mm nanofiber mats (fig. S1) were measured
by mercury porosimetry (Micromeritics, AutoPore IV 9500, IL, USA).
The average pore size of each region in RAS and VAS (Fig. 1, C to F)
was measured on the basis of the SEM images. The channel length
of the RAS and VAS (Fig. 1, G to J) were also measured on the basis
of the SEM images.
Mechanical tests
The mechanical properties of RAS and VAS were examined in the
frontal and side directions, which are defined in fig. S3C. The compressive stress was recorded with an Instron 5640 universal test machine with a 10-N load. For the tests in the frontal direction, the
compressive strain of RAS (4 mm in height, 8 mm in diameter) and
VAS (4 mm in height, 8 mm in diameter) was set as 70% (maximum
compressive strain of RAS and VAS). For the tests in the side direction,
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the compressive strain of RAS (4 mm in length, 4 mm in height,
4 mm in width) and VAS (4 mm in length, 4 mm in height, 4 mm in
width) was the same as the one used in the frontal direction.
BMSC migration on RAS and VAS
The gelatin methacryloyl (Gel-MA) was sterilized with ethylene oxide
for 12 hours. Then, 8% (w/v) of Gel-MA solution with 0.05% (w/v)
2959 photoinitiator was prepared in 0.01 M phosphate-buffered saline
(PBS) buffer (pH 7.4), and 3 ml of the mixed solution was added into
each well of the six-well plate and cross-linked with ultraviolet light
for 1 min. The Gel-MA hydrogels were washed three times with 0.01 M
PBS before use. BMSCs were isolated from Sprague-Dawley rats
(male, 6 months old) following standard procedures. The fourth-
generation of BMSCs was used for the migration study. One milliliter
of BMSCs solution (1 × 107 cells/ml) was seeded on the surface of
8% Gel-MA hydrogel and cultured until the cell confluence reached
90%. Two different in vitro migration models were established. In the
first model, the RAS or VAS were placed on the surface of BMSCs
seeded Gel-MA hydrogel and continuously cultured for 2, 4, and
6 days. In the second model, an 8-mm hole was created by a punch,
and then RAS or VAS were inserted into the hole. The surface of
scaffolds and the surface of hydrogel were kept at the same level and
then continuously cultured for 4, 8, and 12 days.
Immunofluorescent staining and confocal imaging
The BMSCs seeded on the surface of Gel-MA hydrogel without or
with an 8-mm hole were fixed with 4% paraformaldehyde and permeabilized with a 0.1% Triton X-100 solution in PBS. Subsequently,
the BMSCs were stained with Alexa Fluor 546 phalloidin (dilution
1:200) for 20 min. Then, the BMSCs seeded on the surface of Gel-MA
hydrogel without or with an 8-mm hole were imaged by confocal
laser scanning microscopy (CLSM) (Zeiss 880, Oberkochen, Germany).
The z-stack range was set from 0 to 250 m, the interval was set at
10 m, and the tile scans were set as 2 × 2 for hydrogel without a hole,
and 7 × 7 for hydrogel with an 8-mm hole. At each indicated time
point, the BMSCs infiltrated RAS and VAS were collected and fixed
with 4% paraformaldehyde and permeabilized with a 0.1% Triton
X-100 solution in PBS. Then, the scaffolds were stained with Alexa
Fluor 546 phalloidin (dilution 1:400) for 20 min. Last, the RAS and
VAS were imaged by CLSM. In the first migration model, the z-stack
range was set from 0 to 1000 m, and the interval was set at 10 m.
In the second migration model, the z-stack range was set from 0 to
900 m, the interval was set at 10 m, and the tile scan was set as 7 × 7.
Reverse transcription polymerase chain reaction
BMSCs were seeded on the RAS for 5 and 9 days. The BMSCs seeded on wells of a six-well culture plate for 5 and 9 days were used as
control. At each indicated time point, the BMSCs seeded RAS was
placed into RNA-free bead tubes and blended with a bullet blender.
The total RNA was extracted using the RNeasy Mini Kit according
to the manufacturer’s instructions. One microgram of RNA was
used to synthesize cDNA using a reverse transcription reagent kit.
Then, the relative expression of BMP-2, bFGF, VEGF, PDGF-BB,
IGF-1, TGF-1, type 1 Collagen, CXCR4, Cyclin D1, CDK1, Caspase-3,
and BCL-2 was measured by the RT-PCR based on SYBR Green
detecting system, which was performed using an Applied Biosystems
7500 Fast Real-time PCR system (Applied Biosystems, USA) with
the following temperature profile: at 95°C for 3 min, then 40 cycles
at 95°C for 3 s, and at 60°C for 30 s. All primer sequences were
as follows:
BMP-2 forward primer: CACGAGAATGGACGTGCCC, reverse
primer: GGGAAGCAGCAACACTAGAAG;
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bFGF forward primer: TCCATCAAGGGAGTGTGTGC, reverse
primer: TCCGTGACCGGTAAGTGTTG;
VEGF forward primer: GGGTCAAAAACGAAAGCGCA, reverse
primer: TACACGTCTGCGGATCTTGG;
PDGF-BB forward primer: CAAGACGCGTACAGAGGTGT,
reverse primer: GCACTGCACATTGCGGTTAT;
IGF-1 forward primer: AGATGTACTGTGCTCCG, reverse primer:
GCAAAGGATCTTGCGGTGAC;
TGF-1 forward primer: AGGGCTACCATGCCAACTTC, reverse primer: CCACGTAGTAGACGATGGGC;
type 1 collagen forward primer: GGAGAGAGCATGACCGATGG, reverse primer: GGGACTTCTTGAGGTTGCCA;
CXCR4 forward primer: GCCATGGCTGACTGGTACTT, reverse primer: CACCCACATAGACGGCCTTT;
Cyclin D1 forward primer: AGGTCCCCTTGGGATGTGTT,
reverse primer: CTCCCTATACTCAGGGTGATGC;
CDK1 forward primer: GGAACAGAGAGGGTCCGTTG, reverse
primer: AGAGATTTCCCGGATTGCCG;
Caspase-3 forward primer: GGAGCTTGGAACGCGAAGAA,
reverse primer: ACACAAGCCCATTTCAGGGT;
BCL-2 forward primer: CTGGTGGACAACATCGCTCT, reverse
primer: GCATGCTGGGGCCATATAGT.
Critical-sized rat calvarial bone defect model
Ninety-one Sprague-Dawley rats (male, 3 months of age, 380 to 420 g)
were used for the in vivo study. The rat was anesthetized using
4% isoflurane in oxygen for approximately 2 min. Then, rat scalp
was shaved and sterilized with povidone-iodine for 3 min and
cleaned three times with ethanol swabs. The skin, subcutaneous tissue, and periosteum were sequentially incised to expose the calvaria. A critical-sized cranial bone defect (8 mm in diameter) was
created by using a trephine bur mounting on a dentist drill. The
saline solution was continuously added to reduce the temperature
during drilling. In addition, the dura mater was kept intact when
the defect was successfully created. Different treatments were applied to the defects, and then the periosteum was sutured with an
absorbable suture and the skin was sutured with a nonabsorbable
suture. During the surgery, the rat was placed on a heating pad to
maintain its body temperature. The defects without any treatment
were set as the control group (no scaffold) (n = 13). The defects
treated with the RAS were set as the RAS group (n = 13). The defects
treated with the VAS were set as the VAS group (n = 13). The defects treated with the collagen scaffold were set as the collagen
group (n = 13). The defects treated with ST were set as the ST group
(n = 13). The defects treated with SB were set as the SB group (n = 13).
The defects treated with TB were set as the TB group (n = 13). The
rats were individually housed after surgery. Euthanasia by CO2
asphyxiation was performed on the rats after 4 and 8 weeks of
surgery. The rat craniums together with the dura were isolated and
fixed in 10% formalin for 3 days and then transferred to 70% ethanol
for micro-CT scanning.
Micro-CT scanning and data analysis
All cranial bone samples were scanned with a high-resolution
micro-CT scanner (Skyscan 1172, Bruker). The scanning parameters
including voltage (44 kV), current (226 A), and image pixel size
(8.62 m) were used. The analysis of bone volume and bone mineral
density was performed by CTAn software (Bruker). The surface
coverage of regenerated bone was calculated by ImageJ. The 3D reconstruction of the whole cranial bone was performed by CTvol
(Bruker). The bone volume and bone mineral density of healthy
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cranial bone at the age of 4 and 5 months were used as a reference
for comparison among the control, RAS, VAS, and collagen sponge
groups after 4 and 8 weeks of implantation.
Computational simulations
We performed computational simulations to evaluate the distribution of Von Mises stress on tested configurations using COMSOL
Multiphysics (COMSOL Inc., Burlington, MA, USA). To optimize
the STL files exported from the CT scanner, we used the free software Meshmixer (Autodesk Inc., Mill Valley, CA, USA) to smooth
the surfaces with the Mesh Smoothing tool, repair the STL errors
with the Auto-Repair function, and lastly adequately cut the models. We exported the refined models as new STL files and imported
them to COMSOL. To keep the number of elements within a manageable range and the low computational cost, we extracted small
portions (1 mm × 1 mm × 1 mm) from the whole reconstructed
mineral structures. We applied the Solid Mechanics interface for
the structural analysis of 3D models, considering bone as an isotropic linear elastic material. For configurations in healthy, control,
RAS, VAS, and collagen sponge groups, we set the Young’s modulus (E) equal to 0.022 GPa, the average Young’s modulus of rat cranial bone. We set a Poisson’s coefficient () equal to 0.3 for all the
configurations and a value of density dependent on the measured
density of the tested structures (range, 5.62 to 171.88 kg/m3). We set
a boundary load to apply a total force of 5 N on the top surface of
the models and a fixed constraint on the bottom surface, calculating
the solutions of a stationary study. We created a tetrahedral mesh
with up to 160,000 elements, and we evaluated the distribution of
Von Mises stress on the surface of the models and on three section
planes, cut starting from the middle section plane.
Masson trichrome staining
After the micro-CT scanning, the decalcification of all isolated samples was performed with 10% EDTA solution (pH 7.4) for 4 weeks,
and the EDTA solution was changed every week. All decalcified cranial bones were cut along the middle of the defects. All samples
were dehydrated in a graded ethanol series (70 to 100%), embedded
in paraffin, and then 5-m-thick paraffin slides were prepared for
histological. The Masson trichrome staining was performed using
standard protocols in the Tissue Science Facility at UNMC.
Orientation of collagen fibers
Collagen SHG imaging was conducted at the Multiphoton Intravital
and Tissue Imaging core using an upright Olympus FVMPE-RS
microscope equipped with a Spectra-Physics InSight X3 laser and
25× (1.05 numerical aperture) objective. SHG images were collected
using 860-nm excitation with SHG-specific emission collected using
a 432-nm (45 nm bandpass) emission filter. Collagen organization
and alignment were quantified in individual SHG images (509 m ×
509 m × 5 m, 0.497 m/pixel) using CT-FIRE and CurveAlign for
Fibrillar Collagen Quantification software (see References below).
Collagen alignment was calculated as the average of measurements
obtained from 200-m regions of interest within each image.
Immunohistochemical staining
The immunohistochemical staining was performed following procedures previously described (50). The slides were deparaffinized
and rehydrated followed by antigen retrieval in heated citrate buffer
for 5 min (citrate buffer solution, pH 6.0 at 100°C). Nonspecific
antibody binding was prevented with a 5% bovine serum albumin
solution. The sections were incubated with type 2 collagen primary
antibodies overnight at 4°C. Then, the corresponding secondary
antibodies were added and incubated for 1 hour at room temperature,
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followed by incubating for 30 min with prepared VECTASTAIN
ABC-alkaline phosphate (AP) reagent and then incubating with AP
substrate solution for 20 min. Ten randomly selected fields were
examined for each group at each time point and used to assess the
average positive cells per unit area.
Statistical analysis
All data were presented as means ± SD. The statistical analysis was
performed using GraphPad Prism 8.0 software. Differences among
groups were evaluated using one-way analysis of variance (ANOVA)
followed by Tukey’s multiple comparisons test. The values of
P < 0.05 were considered statistically significant. The values of
P < 0.01 were considered statistically very significant.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/31/eabg3089/DC1
View/request a protocol for this paper from Bio-protocol.
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